[Pharmacotherapy for children and adolescents with sleep disorders: an overview]

Katharina Grau1, Paul L Plener1

  • 11 Klinik für Kinder- und Jugendpsychiatrie/-psychotherapie, Universitätsklinikum Ulm.

Insights

Pharmacotherapy for pediatric sleep disorders is considered when non-drug approaches fail. Melatonin shows promise for children with autism spectrum disorder, but evidence for other medications is limited, favoring non-drug treatments.

Area of Science:

  • Pediatric Sleep Medicine
  • Child and Adolescent Psychiatry
  • Pharmacology

Background:

  • Sleep difficulties affect approximately 20% of children and adolescents.
  • Insomnia in minors leads to reduced psychosocial functioning and significant distress.
  • Effective treatment strategies are crucial for this population.

Purpose of the Study:

  • To provide a literature overview on pharmacotherapy for sleep disorders in children and adolescents.
  • To evaluate the evidence for different substance classes in hypnotic indications.
  • To guide clinical decision-making regarding medication use.

Main Methods:

  • Literature review of studies on pharmacotherapy for pediatric sleep disorders.
  • Analysis of substance classes used for hypnotic indications in minors.
  • Examination of evidence for efficacy and tolerability.

Main Results:

  • Melatonin has demonstrated positive effects on sleep in children and adolescents with autism spectrum disorder.
  • Limited evidence exists for the efficacy and tolerability of other medications in primary insomnia or sleep disorders in minors with psychiatric conditions.
  • Non-drug treatment strategies are preferred.

Conclusions:

  • Non-drug interventions for sleep disorders in children and adolescents should be prioritized.
  • Pharmacotherapy should only be considered as a secondary option after careful evaluation.
  • Further research is needed on the efficacy and safety of various medications in pediatric populations.

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
685
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
628
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.6K
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
315
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
323
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
463